External news

FDA approves first-ever glucose monitoring system for weight loss from Signos

Any patient can access Signos’ system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom. Leggi news
Invia per E-mail stampa facebook Più Share on Google+ Share on LinkedIn